Top Institutions in Ophthalmology - Retinal Diseases
Institutions were ranked based on their leadership in retinal disease research, clinical trials in AMD, and development of novel anti-VEGF and tyrosine kinase inhibitor therapies, considering their publication record, ongoing clinical trials, and translational research programs.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with extensive expertise in retinal diseases and leads numerous clinical trials in neovascular AMD, including novel anti-VEGF and sustained-release therapies.
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear has a robust retinal research division with pioneering work in anti-VEGF therapies and innovative drug delivery systems for AMD, contributing significantly to clinical trial design and novel therapeutic development.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its clinical and basic science research in retinal diseases, including AMD, with active involvement in early-phase trials of novel anti-VEGF agents and sustained-release implants.
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a leading ophthalmology department with active research in novel AMD therapies, including sustained-release drug delivery systems and tyrosine kinase inhibitors, supported by strong clinical trial infrastructure.
-
#5
Mayo Clinic
Rochester, MN
Mayo Clinic combines clinical excellence with research in retinal diseases, contributing to clinical trials of new AMD therapies and advancing understanding of treatment durability and efficacy.